Molecular pathways in virus-induced cytokine production

Microbiology and Molecular Biology Reviews

Volumn 65, Issue 1, 2001, Pages 131-150

  Mogensen, T H ^a   Paludan, S R ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CHEMOKINE; CYCLIC AMP; CYTOKINE; DOUBLE STRANDED RNA; GAMMA INTERFERON; GLYCOPROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 1BETA; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; RANTES; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; UNINDEXED DRUG; VIRUS PROTEIN;

CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; HEPATITIS B VIRUS; HERPES SIMPLEX VIRUS; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS 1; INFLAMMATION; INFLUENZA VIRUS; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS INFECTION;

ANIMALS; CYTOKINES; CYTOMEGALOVIRUS; DISEASE MODELS, ANIMAL; HERPESVIRUS 4, HUMAN; HIV; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; ORTHOMYXOVIRIDAE; SIGNAL TRANSDUCTION; VIRUS DISEASES; VIRUSES;

CYTOMEGALOVIRUS; HEPATITIS B VIRUS; HERPES; HUMAN HERPESVIRUS 4; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; INFLUENZA VIRUS; SIMPLEXVIRUS;

EID: 0035098881     PISSN: 10922172     EISSN: None     Source Type: Journal    
DOI: 10.1128/MMBR.65.1.131-150.2001     Document Type: Review

References (272)

1. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases
2. Cell activation signals and the pathogenesis of human cytomegalovirus
3. Cytokine profile of viral and autoimmune chronic active hepatitis
4. HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enhancer-binding protein β (NF-IL6) transcription factors
5. Recombinant gp120 induces IL-10 in resting peripheral blood mononuclear cells: Correlation with the induction of other cytokines
6. The transcriptional function of the hepatitis B virus X protein and its role in hepatocarcinogenesis
7. Interferon induction by HIV glycoprotein 120: Role of the V3 loop
8. Induction of interferon-α by glycoprotein D of herpes simplex virus: A possible role of chemokine receptors
9. Modulation of murine macrophage responses stimulated with influenza glycoproteins
10. Expression of constitutively active 1κBβ in T cells of transgenic mice: Persistent NF-κB activity is required for T-cell immune responses
11. Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes
12. Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes
13. Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-κB site
14. Constitutive expression of various chemokine genes in human T-cell lines infected with human T-cell leukemia virus type I: Role of the viral transactivator Tax
15. Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages
16. The mutant plasmacytoma cell line S107 allows the identification of distinct pathways leading to NF-κB activation
17. The Epstein-Barr virus and its association with human cancers
18. Influenza: Pathogenesis and host defense
19. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras. Raf. MAP kinase signaling cascade
20. Hepatitis B virus HBx protein induces transcription factor AP-I by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases
21. Human T-cell leukemia virus type I Tax associates with and is negatively regulated by the NF-κB2 p100 gene product: Implications for viral latency
22. Regulation of the human interleukin-5 promoter by Ets transcription factors. Ets1 and Ets2, but not Elf-1, cooperate with GATA3 and HTLV-1 Tax1
23. Increased levels of sequence-specific DNA-binding proteins in human cytomegalovirus-infected cells
24. Signaling through the EBV/C3d receptor (CR2, CD21) in human B lymphocytes: Activation of phosphatidylinositol 3-kinase via a CD19-independent pathway
25. Epstein-Barr virus/C3d receptor (CR2, CD21) activated by its extracellular ligands regulates pp105 phosphorylation through two distinct pathways
26. Receptor-binding properties of a soluble form of human cytomegalovirus glycoprotein B
27. Engagement of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferon-responsive pathway
28. Extracellular Tax1 protein stimulates NF-κB and expression of NF-κB-responsive Ig κ and TNF β genes in lymphoid cells
29. Interleukin 10 is induced by recombinant HIV-1 Nef protein involving the calcium/calmodulin-dependent phosphodiesterase signal transduction pathway
30. Hypothesis: A role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis
31. The human interferonγ gene contains an inducible promoter that can be transactivated by tax I and II
32. Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300
33. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2)
34. Expression of transcription factor genes after influenza A virus infection
35. Epstein-Barr virus transformation: Involvement of latent membrane protein 1-mediated activation of NF-κB
36. Human immunodeficiency virus type 1 gp120 stimulates cytomegalovirus replication in monocytes: Possible role of endogenous interleukin-8
37. The enhanceosome and transcriptional synergy
38. Cytomegalovirus induction of interleukin-6 in lung fibroblasts occurs independently of active infection and involves a G protein and the transcription factor, NF-κB
39. The Tat protein of HIV-1 induces tumor necrosis factor-α production. Implications for HIV-1-associated neurological diseases
40. Autoregulation of IκB α activity
41. HIV-1 envelope glycoproteins induce activation of activated protein-1 in CD4+ T cells
42. Hepatitis B virus immunopathology
43. Interaction of hepatitis B viral X protein and CCAAT/enhancer-binding protein α synergistically activates the hepatitis B viral enhancer IL/pregenomic promoter
44. Interferon induction by influenza virus: Significance of neuraminidase
45. JNK2 and IKKβ are required for activating the innate response to viral infection
46. Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat
47. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals
48. A TH1→TH2 switch is a critical step in the etiology of HIV infection
49. The V domain of herpesvirus Ig-like receptor (HIgR) contains a major functional region in herpes simplex virus-1 entry into cells and interacts physically with the viral glycoprotein D
50. Human immunodeficiency virus vpr product is a virion-associated regulatory protein
51. Specific Th1 cytokine down-regulation associated with primary clinically derived human immunodeficiency virus type 1 Nef gene-induced expression
52. The role of HIV 1 Nef in T-cell activation: Nef impairs induction of Th1 cytokines and interacts with the Src family tyrosine kinase
53. Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate
54. Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-κB binding and protein kinase C activity in primary human astrocytes
55. Induction of tumor necrosis factor α in human neuronal cells by extracellular human T-cell lymphotropic virus type I Tax
56. +, calcineurin, and NF-AT
57. Evidence for an antiviral effect of nitric oxide-inhibition of herpes simplex virus type 1 replication
58. Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine-threonine kinases
59. The role of Nef in the replication cycle of the human and simian immunodeficiency viruses
60. Binding of the Epstein-Barr virus major envelope glycoprotein gp350 results in the upregulation of the TNF-α gene expression in monocytic cells via NF-κB involving PKC. PI3-K and tyrosine kinases
61. Epstein-Barr virus envelope glycoprotein gp350 induces NF-κB activation and IL-1β synthesis in human monocytes-macrophages involving PKC and P13-K
62. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5
63. Adenovirus-mediated human immunodeficiency virus-I Nef expression in human monocytes/macrophages and effect of Nef on downmodulation of Fcγ receptors and expression of monokines
64. Nuclear IκBβ maintains persistent NF-κB activation in HIV-1-infected myeloid cells
65. Activation of transcription factor NF-κB by the Tat protein of human immunodeficiency virus type 1
66. Human immunodeficiency virus type 1 tat protein activates transcription factor NF-κB through the cellular interferon-inducible, double-stranded RNA-dependent protein kinase
67. Extracellular human T-cell lymphotropic virus type 1 Tax protein induces cytokine production in adult human microglial cells
68. Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production
69. Autocrine secretion of interferon-α/β and turnout necrosis factor-α synergistically activates mouse macrophages after infection with herpes simplex virus type 2
70. Stimulus-specific assembly of enhancer complexes on the tumor necrosis factor α gene promoter
71. Up-regulation of NK cytotoxic activity, via IL-15 induction by different viruses: A comparative study
72. Influenza virus-induced NF-κB-dependent gene expression is mediated by overexpression of viral proteins and involves oxidative radicals and activation of IκB kinase
73. Induction of IFN-α by HIV-1 in monocyte-enriched PBMC requires gp120-CD4 interaction but not virus replication
74. HIV-1: Fifteen proteins and an RNA
75. Transactivation by the human T-cell leukemia virus Tax protein is mediated through enhanced binding of activating transcription factor-2 (ATF-2) ATF-2 response and cAMP element-binding protein (CREB)
76. Soluble Nef antigen of HIV-1 is cytotoxic for human CD4+ T cells
77. Functional activation of the long terminal repeat of human T-cell leukemia virus type I by a trans-acting factor
78. Molecular interactions involved in the transactivation of the human T-cell leukemia virus type 1 promoter mediated by Tax and CREB-2 (ATF-4)
79. Human T-cell leukemia virus type 1 Tax induction of NF-κB involves activation of the IκB kinase α (IKKα) and IKKβ cellular kinases
80. Study on proinflammatory cytokines (IL-1 β, IL-6, TNF-α) and IL-2 in patients with acute hepatitis B
81. Cytokine expression by human peripheral blood dendritic cells stimulated in vitro with HIV-1 and herpes simplex virus
82. Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule
83. Induction of tumor necrosis factor α production by human hepatocytes in chronic viral hepatitis
84. Constitutive dephosphorylation and activation of a member of the nuclear factor of activated T cells. NF-AT1, in Tax-expressing and type I human T-cell leukemia virus-infected human T cells
85. Activation of the IL-2 gene promoter by HTLV-1 tax involves induction of NF-AT complexes bound to the CD28-responsive element
86. Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection
87. Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1
88. IKKγ serves as a docking subunit of the IκB kinase (IKK) and mediates interaction of IKK with the human T-cell leukemia virus Tax protein
89. Role of Sp1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat
90. Mutant influenza viruses with a defective NSI protein cannot block the activation of PKR in infected cells
91. NF-κB and the innate immune response
92. pX, the HBV-encoded coactivator, interacts with components of the transcription machinery and stimulates transcription in a TAF-independent manner
93. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense
94. Kinetics of cytokine production in the cornea and trigeminal ganglion of C57BL/6 mice after corneal HSV-1 infection
95. Hepatitis B virus transcriptional activators: Mechanisms and possible role in oncogenesis
96. A kinetic study of immune mediators in the lungs of mice infected with influenza A virus
97. p38 MAPK signalling cascades in inflammatory disease
98. The hepatitis B virus large surface protein (LHBs) is a transcriptional activator
99. Costimulation of cytokine gene expression in T cells by the human T leukemia/lymphotropic virus type 1 trans activator Tax
100. HIV-1 tat protein induces the production of interleukin-8 by human brain-derived endothelial cells
101. Susceptibility of mononuclear phagocytes to influenza A virus infection and possible role in the antiviral response
102. Mechanisms of T-cell activation by human T-cell lymphotropic virus type I
103. Pathogenesis of diseases induced by human lymphotropic, virus type 1 infection
104. Human influenza virus neuraminidase, but not hemagglutinin, induces murine macrophage interleukin I in vivo and in vitro
105. Stimulation of tumor necrosis factor secretion by purified influenza virus neuraminidase
106. Cytokine release of peripheral blood mononuclear cells in children with chronic hepatitis B virus infection
107. Epstein-Barr virus-associated malignancies: Epidemiologic patterns and etiologic implications
108. Transcriptional up-regulation of interleukin 4 receptors by human immunodeficiency virus type 1 tat gene
109. Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type 1
110. HIV type 1 Tat protein inhibits interleukin 12 production by human peripheral blood mononuclear cells
111. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-κB
112. GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase
113. Activation of the cellular transcription factor AP-1 in herpes simplex virus infected cells is dependent on the viral immediate-early protein ICP0
114. Production of influenza-stimulated tumor necrosis factor-α by monocytes following acute influenza infection in humans
115. Resistance of mice deficient in IL-4 to retrovirus-induced immunodeficiency syndrome (MAIDS)
116. HSV-1-mediated modulation of cytokine gene expression in a permissive cell line: Selective upregulation of IL-6 gene expression
117. The Epstein-Barr virus nuclear antigen 2 (EBNA2), a protein required for B lymphocyte immortalization, induces the synthesis of type 1 interferon in Burkitt's lymphoma cell lines
118. Inhibition of viral replication by interferon-γ-induced nitric oxide synthase
119. Hepatitis B virus transactivator HBx uses a tumor promoter signalling pathway
120. Purified Tat induces inflammatory response genes in Kaposi's sarcoma cells
121. The role of ATF in regulating the human cytomegalovirus DNA polymerase (UL54) promoter during viral infection
122. Transactiviation of the transforming growth factor β 1 (TGF-β 1) gene by human T lymphotropic virus type 1 tax: A potential mechanism for the increased production of TGF-β 1 in adult T cell leukemia
123. The mechanism of transcriptional synergy of an in vitro assembled interferon-β enhanceosome
124. The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor
125. The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells
126. Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-κB
127. Role of oxidants in influenza virus-induced gene expression
128. p38 mitogen-activated protein kinase and c-jun-NH2-terminal kinase regulate RANTES production by influenza virus-infected human bronchial epithelial cells
129. HIV-Tat protein activates c-Jun N-terminal kinase and activator protein-1
130. Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: Role of IRF-1 and NF-κB
131. Analysis of HCF, the cellular cofactor of VP16, in herpes simplex virus-infected cells
132. Interactions between HTLV-I Tax and NF-κB/Rel proteins in T cells
133. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome
134. Constitutive production of interleukin-6 and tumor necrosis factor-α from spontaneously proliferating T cells in patients with human T-cell lymphotropic virus type-I/II
135. Human immunodeficiency virus type 1 and its coat protein gp120 induce apoptosis and activate JNK and ERK mitogen-activated protein kinases in human neurons
136. Overproduction of NFKB2 (lyt-10) and c-Rel: A mechanism for HTLV-1 Tax-mediated trans-activation via the NF-κB signalling pathway
137. The hepatitis B virus X protein activates nuclear factor of activated T cells (NF-AT) by a cyclosporin A-sensitive pathway
138. The hepatitis B virus X protein up-regulates tumor necrosis factor α gene expression in hepatocytes
139. Upregulation of tumor necrosis factor-α gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome
140. Expression of Th1 and Th2 type cytokines responding to HBsAg and HBxAg in chronic hepatitis B patients
141. The interferon-induced double-stranded RNA-activated human p68 protein kinase potently inhibits protein synthesis in cultured cells
142. Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells
143. Role of tyrorine kinases, protein kinase C, and protein kinase A in the regulation of interferon-α production induced by herpes simplex virus type 1
144. The human T-cell leukemia virus type-1 Tax protein regulates the activity of the IκB kinase complex
145. The human immunodeficiency virus type 1 Tat protein up-regulates the promoter activity of the β-chemokine monocyte chemoattractant protein 1 in the human astrocytoma cell line U-87 MG: Role of SP-1, AP-1, and NF-κB consensus sites
146. Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription
147. Hepatitis B virus X protein is a transcriptional modulator that communicates with transcription factor IIB and the RNA polymerase II subunit 5
148. Induction of nuclear NF-κB DNA binding activity after exposure of lymphoid cells to soluble tax1 protein
149. Human T-cell lymphotropic virus type I Tax1 activation of NF-κB: Involvement of the protein kinase C pathway
150. Release of lymphokines after Epstein Barr virus infection in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans
151. Reciprocal modulatory interaction between human immunodeficiency virus type I Tat and transcription factor NFAT1
152. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions
153. Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor κB and CCAAT/enhancer-binding protein-like cis-elements
154. Herpes simplex virus type 2 induces interleukin-12 by macrophages through a mechanism involving NF-κB
155. Differential viral induction of distinct interferon-α genes by positive feedback through interferon regulatory factor-7
156. Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-κB and AP-I
157. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development
158. EBV induces the production and release of IL-8 and macrophage inflammatory protein-1α in human neutruphils
159. Activation of cJUN N-terminal kinase by herpes simplex virus type 1 enhances viral replication
160. The cellular inhibitor of the PKR protein kinase, P58(IPK), is an influenza virus-activated co-chaperone that modulates heat shock protein 70 activity
161. + HTLV-1 specific cytotoxic T cells
162. Recruitment of CBP/p300 by the IFN β enhanceosome is required for synergistic activation of transcription
163. Human cytomegalovirus carries serine/threonine protein phosphatases PP1 and a host-cell derived PP2A
164. Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired inmunodeficiency syndrome
165. Extracellular HIV-1 Tat protein differentially activates the JNK and ERK/MAPK pathways in CD4 T cells
166. A CD4-independent interaction of human immunodeficiency virus-1 gp120 with CXCR4 induces their cointernalization, cell signaling, and T-cell chemotaxis
167. Role of interleukin-12 in primary influenza virus infection
168. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/ NGF receptor family
169. Human T-cell leukemia virus type I Tax transactivates human interleukin 8 gene through acting concurrently on AP-1 and nuclear factor-κB-like sites
170. Transactivation of the interleukin-1α, promoter by human T-cell leukemia virus type I and type II Tax proteins
171. Interleukin-10 gene expression and adult T-cell leukemia
172. Human T-cell leukemia virus type I tax transactivates the interleukin-6 gene in human rheumatoid synovial cells
173. The Epstein-Barr virus transforming protein LMPI engages signaling proteins for the tumor necrosis factor receptor family
174. An inducible transcription factor activates expression of human immunodeficiency virus in T cells
175. The Epstein-Barr virus latent membrane protein-1 (LMPI) induces interleukin-10 production in Burkitt lymphoma lines
176. Constitutive expression and production of tumor necrosis factor-β in T-cell lines infected with HTLV-I and HTLV-II
177. Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon
178. Ras- and Raf-dependent activation of c-jun transcriptional activity by the hepatitis B virus transactivator pX
179. p38-dependent activation of interferon regulatory factor 3 by lipopolysaccharide
180. Cytomegalovirus activates interferon immediate-early response gene expression and an interferon regulatory factor 3-containing interferon-stimulated response element-binding complex
181. The CXC chemokine SDF-1 is the ligand fur LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1
182. Effect of hepatitis B virus on tumour necrosis factor (TNF α) gene expression in human THP-1 monocytic and Namalwa B cell lines
183. An absolute and restricted requirement for IL-12 in natural killer cell IFN-γ production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections
184. Expression of influenza virus hemagglutinin activates transcription factor NF-κB
185. The ER overload response: Activation of NF-κB
186. NF-κB activation is responsible for the synergistic effect of herpes simplex virus type 2 infection on interferon-γ-induced nitric oxide production
187. Inhibition of NO production in macrophages by IL-13 is counteracted by HSV infection through TNF-α-induced activation of NF-κB
188. Interferon (IFN)-γ and herpes simplex virus/tumor necrosis factor-α synergistically induce nitric oxide synthase 2 in macrophages through cooperative action of nuclear factor-κB and IFN regulatory factor-1
189. Herpes simplex type I inductlon of persistent NF-κB nuclear translocation increases the efficiency of virus replication
190. HIV-1 gp120 induces IL-4 and IL-13 release from human FcεR1 + cells through interaction with the VH3 region of IgE
191. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B
192. Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis factor-α-mediated mechanism
193. Regulation of IκB β in WEHI 231 mature B cells
194. Virus infection activates IL-1β and IL-18 production in human macrophages by a caspase-1-dependent pathway
195. Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway
196. Binding of human immunodeficiency virus type 1 to CD4 induces association of Lck and Raf-1 and activates Raf-1 by a Ras-independent pathway
197. An IκB homolog encoded by African swine fever virus provides a novel mechanism for downregulation of proinflammatory cytokine responses in host macrophages
198. Gangliosides activate cultured rat brain microglia
199. Induction of interleukin-15 production by HIV-1 Nef protein: A role in the proliferation of uninfected cells
200. The role of herpes simplex virus glycoproteins in the virus replication cycle
201. Inhibition of nuclear factor κB activation by a virus-encoded IκB-like protein
202. Relation of α and γ interferon levels to development of AIDS in homosexual men
203. Involvement of NF-AT in type I human T-cell leukemia virus Tax-mediated Fas ligand promoter transactivation
204. Epstein-Barr virus induces GM-CSF synthesis by monocytes: Effect on EBV-induced IL-1 and IL-1 receptor antagonist production in neutrophils
205. The IL-1 and IL-1 receptor antagonist (IL-1Ra) response of human neutrophils to EBV stimulation. Preponderance of IL-Ra detection
206. HSV-1-inducible proteins bind to NF-κB-like sites in the HSV-1 genome
207. Time course of chemokines in the cerebrospinal fluid and serum during herpes simplex type 1 encephalitis
208. Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B
209. Activation of transcription factors NF-κB and NF-1L-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression
210. Regulation of HIV-1 long terminal repeats by interaction of C/ EBP(NF-1L6) and NF-κB/Rel transcription factors
211. NF-κB activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation
212. Concurrent production of interleukin-2, interleukin-10, and γ interferon in the regional lymph nodes of mice with influenza pneumonia
213. Influenza A virus-induced IFN-α/β and IL-18 synergistically enhance IFN-γ gene expression in human T cells
214. Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-β gene
215. Cooperative actions of HIV-1 Vpr and p53 modulate viral gene transcription
216. Regulation of TNFα and TGFβ-1 gene transcription by HIV-1 Tat in CNS cells
217. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus I tat protein
218. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1
219. Cooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type I long terminal repeat in vivo can occur in the absence of the TAR binding site
220. Human immunodeficiency virus type 1 gp120 induces anergy in human peripheral blood lymphocytes by inducing interleukin-10 production
221. Synthesis and function of influenza A virus glycoproteins
222. Downregulation of IL-10 secretion and enhanced antigen-presenting abilities following HTLV-I infection of T cells
223. Influenza virus neuraminidase activates latent transforming growth factor β
224. In vivo transduction: Delivery of a biologically active protein into the mouse
225. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro
226. Interleukin-18, interferon-γ, IP-10, and Mig expression in Epstein-Barr virus-induced infectious mononucleosis and posttransplant lymphoproliferative disease
227. Human T-cell lymphotrophic virus type-I tax gene induces secretion of human macrophage inflammatory protein-Iα
228. Structure, regulation and function of NF-κB
229. Hepatitis B virus HBx protein activates transcription factor NF-κB by acting on multiple cytoplasmic inhibitors of rel-related proteins
230. Epstein-Barr virus binding to CD21 activates the initial viral promoter via NF-κB induction
231. Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-κB through a pathway that includes the NF-κB-inducing kinase and the IκB kinases IKKα and IKKβ
232. Possible involvement of double-stranded RNA-activated protein kinase in cell death by influenza virus infection
233. Induction of interleukin-6 after stimulation of human B-cell CD21 by Epstein-Barr virus glycoproteins gp350 and gp220
234. Constitutive overexpression of the L-selectin gene in fresh leukemic cells of adult T-cell leukemia that can be transactivated by human T-cell lymphotropic virus type 1 Tax
235. Distinct organ-dependent mechanism for the control of murine cytomegalovirus infection by natural killer cells
236. Herpes simplex virus replication-induced expression of chemokines and proimflammatory cytokines in the eye: Implications in herpetic stromal keratitis
237. IκB-β regulates the persistent response in a biphasic activation of NF-κB
238. Stimulation of IFN-α production in HLA-DR+, light density peripheral blood mononuclear cells by human immunodeficiency virus
239. Human T-cell leukemia virus type I Tax transactivates the promoter of human prointerleukin-1β gene through association with two transcription factors, nuclear factor-interleukin-6 and Spi-I
240. Human immunodeficiency virus type- 1 tat enhances interleukin-2 promoter activity through synergism with phorbol ester and calcium-mediated activation of the NF-AT cis-regulatory motif
241. Hydrolysis of inositol lipids: An early signal of human cytomegalovirus infection
242. HBV-specific lymphoproliferative and cytokine responses in patients with chronic hepatitis B
243. Blocking HIV co-receptors by chemokines
244. Induction of Sp1 phosphorylation and NF-κB-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid
245. Local production of tumor necrosis factor α. interleukin 1 and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response
246. Correlation of virus replication, cytokine (TNF-α and IL-1) producing cells, neuronal necrosis and inflammation after intranasal infection of mice with herpes simplex virus strains of different virulence
247. The hepatitis B virus X protein increases the cellular level of TATA-binding protein, which mediates transactivation of RNA polymerase III genes
248. Interaction of virion protein Vpr of human immunodeficiency virus type I with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat
249. Influenza A virus NS1 protein prevents activation of NF-κB and induction of alpha/beta interferon
250. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-β enhancer in vivo
251. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1
252. Human immunodeficiency virus type I Tat upregulates interleukin-2 secretion in activated T cells
253. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways
254. The role of the dsRNA-activated protein kinase, PKR, in signal transduction
255. Role of the dsRNA-activated protein kinase (PKR) in cell regulation
256. Domain-specific interaction with the IκB kinase (IKK) regulatory subunit IKK-γ as an essential step in tax-mediated activation of IKK
257. Constitutively activated JNK is associated with HTLV-I mediated tumorigenesis
258. Triple synergism of human T-lymphotropic virus type I-encoded tax, GATA-binding protein, and AP-1 is required for constitutive expression of the interleukin-5 gene in adult T-cell leukemia cells
259. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase
260. Tumor necrosis factor α and interferon γ synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-κB-like binding sites of the interleukin 8 gene
261. The role of HMG I(Y) in the assembly and function of the IFN-β enhanceosome
262. HTLV-I Tax protein binds to MEKK1 to stimulate IκB kinase activity and NF-κB activation
263. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(κ)B kinase-β
264. Direct triggering of the type I interferon system by virus infection: Activation of a transcription factor complex containing IRF-3 and CBP/p300
265. Regulation of transforming growth factor-β 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis
266. Human cytomegalovirus binding to human monocytes induces immunoregulatory gene expression
267. The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-κB during infection
268. Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-κB promoters
269. Herpes simplex virus type I infection stimulates p38/c-Jun N-terminal mitogen-activated protein kinase pathways and activates transcription factor AP-1
270. NF-κB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-κB-inducing kinase and IκB kinase
271. + channel involved in the control of the resting potential in CEM lymphocytes
272. Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein I